FSTX - F-Star Therapeutics Inc. (FSTX) CEO Eliot Forster On Q4 2021 Results - Earnings Call Transcript
F-star Therapeutics, Inc. (FSTX) Q4 2021 Earnings Conference Call March 14, 2022 9:00 AM ET Company Participants Lindsey Trickett - VP of IR Eliot Forster - CEO Darlene Deptula-Hicks - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Company Daina Graybosch - SVB Leerink Matt Phipps - William Blair Justin Walsh - B. Riley Securities Yale Jen - Laidlaw & Company Jason Shieh - HC Wainwright Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:02 Good day, and thank you for standing by. Welcome to the F-star Therapeutics Fourth Quarter 2021 Full-Year Earnings Conference Call. At this time, all participants are in a listen-only mode. After the
For further details see:
F-Star Therapeutics, Inc. (FSTX) CEO Eliot Forster On Q4 2021 Results - Earnings Call Transcript